Class IOngoingD-0397-2026
Drug recall · March 11, 2026
MR. 7 SUPER 700000 capsules recall
Why: Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7
- Lots / codes
All codes; Exp 12/31/2029
- Quantity
- 4
- Company
- StuffbyNainax, Huntsville, TX
- Distribution
- Product was distributed to 4 customers in the US.
- Initiated
- December 15, 2025 · Voluntary: Firm initiated
- Classified
- March 18, 2026
- Reported
- March 11, 2026
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.